Hidekazu Miyake

This inventor holds 12 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Maruko Seiyaku Co., Ltd., Seiyaku Co., Ltd.. Active years: 1980-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidekazu Miyake. Retrieved from https://idiyas.com/inventor/hidekazu-miyake-i6eur48y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12

% Patents Active = 91.7

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 107(Granted Patents)

Company Filing History:

12 out of 320

Taiho Pharmaceutical Company Limited

patents

1 out of 8

Maruko Seiyaku Co., Ltd.

where one patent can have more than one assignee

Years Active: 1980-2008

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7417175 - Interstitial prostatism model animal (2008-08-26),

2. 4666911 - Allophanoylpiperazine compound and analgesic composition containing same (1987-05-19),

3. 4443607 - 1(2H)-Isoquinolone compounds and acid addition salts thereof (1984-04-17),

4. 4393210 - 1(2H)-Isoquinolone compounds and acid addition salts thereof (1983-07-12),

5. 4371544 - Pharmaceutical composition containing 1,1,3,5-substituted biuret compound (1983-02-01),

6. 4350700 - Pharmaceutical composition containing 1,3,5-substituted biuret compound (1982-09-21),

7. 4293713 - Novel 1,1,3,5-substituted biuret compound and a pharmaceutical (1981-10-06),

8. 4287207 - Pharmaceutical composition containing 1,3,5-substituted biuret compound (1981-09-01),

9. 4278672 - Pharmaceutical composition and methods of use containing (1981-07-14),

10. 4243812 - Processes for the preparation of glyoxal-2-oxims (1981-01-06),

11. 4224450 - Process for the preparation of glyoxal-2-oximes (1980-09-23),

12. 4212874 - Glyoxal-2-oxim derivatives and a process for relieving pain/or (1980-07-15),

Title: The Innovative Achievements of Hidekazu Miyake

Introduction

Hidekazu Miyake is a prolific inventor based in Tokushima, Japan, renowned for his contributions to the field of medical innovation. With a remarkable portfolio consisting of 12 patents, Miyake has dedicated his career to developing groundbreaking solutions that address significant health challenges. His research primarily focuses on urology and analgesics, providing advancements that could enhance patient care.

Latest Patents

Miyake's latest inventions include an animal model for interstitial prostatism, which serves as a tool for screening substances aimed at preventing or treating human benign prostatic hyperplasia. This innovative model is created by implanting the fetal urogenital sinus from a non-human animal, allowing researchers to measure the effectiveness of various test substances on the implanted tissue.

Another notable invention is an analgesic composition that utilizes an allophanoylpiperazine compound as its active ingredient. The complex structure of this compound, which includes various chemical groups, highlights Miyake's commitment to developing effective pain management solutions.

Career Highlights

Throughout his career, Miyake has collaborated with significant companies in the pharmaceutical industry, such as Taiho Pharmaceutical Company Limited and Maruko Seiyaku Co., Ltd. His experience and expertise have earned him recognition within his field, contributing to advancements in pharmaceutical research and development.

Collaborations

Miyake has worked alongside esteemed colleagues, including Takaji Honna and Takahiro Yabuuchi. Together, they have pursued innovative research initiatives that aim to translate laboratory discoveries into practical applications for patients.

Conclusion

Hidekazu Miyake's innovative contributions to the fields of urology and analgesics exemplify the impact that dedicated inventors can have on healthcare. His patented inventions not only demonstrate his expertise in scientific research but also highlight his commitment to improving patient outcomes through innovative solutions. As he continues to push the boundaries of medical technology, Miyake remains a significant figure in the landscape of modern medicine.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]